PPP1R14A and central nervous system cancer: Investigating the correlation of PPP1R14A expression with DSS of patients indicated that high expression of PPP1R14A unfavorably impacted DSS in ACC (p = 0.001), BLCA (p = 0.014), CESC (p < 0.0001), COAD (p = 0.002), ESCA(p = 0.018), gliomas (p < 0.001), KIRP (p = 0.001), READ (p = 0.01), SKCM (p = 0.032), STAD (p = 0.004), and friendly influenced LIHC (p = 0.045) (Figure 5).